{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:22:33Z","timestamp":1774009353819,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","award":["724134696"],"award-info":[{"award-number":["724134696"]}],"id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrc.2026.153331","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:46:38Z","timestamp":1769705198000},"page":"153331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanoemulsion in cancer therapy: Enhancing the therapeutic efficacy of capecitabine and 5-fluorouracil in colorectal cancer with thymoquinone nanoemulsion"],"prefix":"10.1016","volume":"805","author":[{"given":"Sama","family":"Torkashvand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-5745","authenticated-orcid":false,"given":"Sohrab","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0100-978X","authenticated-orcid":false,"given":"Ali Akbar","family":"Moghadamnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrc.2026.153331_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153331_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153331_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/1120009X.2021.1920247","article-title":"Performance of capecitabine in novel combination therapies in colorectal cancer","volume":"33","author":"Pouya","year":"2021","journal-title":"J. Chemother."},{"key":"10.1016\/j.bbrc.2026.153331_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122083","article-title":"Combination chemotherapy against colorectal cancer cells: co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers","volume":"332","author":"Pouya","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.153331_bib5","first-page":"79","article-title":"Capecitabine in the management of colorectal cancer","volume":"3","author":"Hirsch","year":"2011","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153331_bib6","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s12253-019-00587-3","article-title":"Comparison of capecitabine (Xeloda) vs. combination of capecitabine and oxaliplatin (XELOX) as neoadjuvant CRT for locally advanced rectal cancer","volume":"25","author":"Yaghobi","year":"2019","journal-title":"Pathol. Oncol. Res."},{"issue":"5 Suppl 10","key":"10.1016\/j.bbrc.2026.153331_bib7","first-page":"72","article-title":"Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy","volume":"27","author":"Sobrero","year":"2000","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153331_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/annonc\/mdn592","article-title":"Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer","volume":"20","author":"Andreetta","year":"2009","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153331_bib9","first-page":"1063","article-title":"Prognostic role of thymidylate synthase, thymidine phosphorylase\/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer","volume":"6","author":"van Triest","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153331_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.49441","article-title":"Clinical benefits and utility of pretherapeutic DPYD and UGT1A1 testing in gastrointestinal cancer: a secondary analysis of the PREPARE randomized clinical trial","volume":"7","author":"Roncato","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/molecules27010226","article-title":"Insights into the protective effects of thymoquinone against toxicities induced by chemotherapeutic agents","volume":"27","author":"Farooq","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153331_bib12","first-page":"950","article-title":"Thymoquinone: an emerging natural drug with a wide range of medical applications","volume":"17","author":"Khader","year":"2014","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"21","key":"10.1016\/j.bbrc.2026.153331_bib13","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16431","article-title":"Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells","volume":"8","author":"Pang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1389450118666170612095959","article-title":"Insights into the targeting potential of thymoquinone for therapeutic intervention against triple-negative breast cancer","volume":"19","author":"Barkat","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153331_bib15","doi-asserted-by":"crossref","first-page":"10421","DOI":"10.1002\/jcp.27710","article-title":"Thymoquinone\u2010induced antitumor and apoptosis in human lung adenocarcinoma cells","volume":"234","author":"Samarghandian","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2026.153331_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1134\/S0006350916060154","article-title":"Thymoquinone, a biologically active component of Nigella sativa, induces mitochondrial production of reactive oxygen species and programmed death of tumor cells","volume":"61","author":"Martinovich","year":"2016","journal-title":"Biophysics"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153331_bib17","article-title":"Anticancer drugs with chemotherapeutic interactions with thymoquinone in osteosarcoma cells","volume":"20","author":"Sarman","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153331_bib18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3748\/wjg.v23.i7.1171","article-title":"Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation","volume":"23","author":"Hsu","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153331_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/17425247.2020.1730808","article-title":"Nanocarriers: more than tour de force for thymoquinone","volume":"17","author":"Rathore","year":"2020","journal-title":"Expet Opin. Drug Deliv."},{"issue":"23","key":"10.1016\/j.bbrc.2026.153331_bib20","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/jnt\/9477202","article-title":"Thymoquinone\u2010loaded nanoemulsion against 5\u2010Fluorouracil\u2013Induced cytotoxicity in vitro and in vivo","volume":"2024","author":"Alimoradi","year":"2024","journal-title":"J. Nanotechnol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153331_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70276","article-title":"Combination of 5-Fluorouracil and thymoquinone for enhanced cytotoxicity, genotoxicity and apoptosis in colorectal cancer: in vitro and in vivo studies","volume":"39","author":"Guler","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153331_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1634\/theoncologist.7-4-288","article-title":"Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review","volume":"7","author":"Malet-Martino","year":"2002","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153331_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nano9060821","article-title":"Current applications of nanoemulsions in cancer therapeutics","volume":"9","author":"S\u00e1nchez-L\u00f3pez","year":"2019","journal-title":"Nanomaterials"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153331_bib25","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.3390\/ijms25105171","article-title":"Revolution in cancer treatment: how are intelligently designed nanostructures changing the game?","volume":"25","author":"G\u00fcl","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12896-025-00958-6","article-title":"Impacts of loading thymoquinone to gold or silver nanoparticles on the efficacy of anti-tumor treatments in breast cancer with or without chemotherapeutic cisplatin","volume":"25","author":"Gomaa","year":"2025","journal-title":"BMC Biotechnol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153331_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00280-016-3054-2","article-title":"Therapeutic drug monitoring of 5-fluorouracil","volume":"78","author":"Lee","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153331_bib28","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8612","article-title":"5-Fluorouracil and capecitabine therapies for the treatment of colorectal cancer","volume":"50","author":"Alzahrani","year":"2023","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153331_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2174\/1389201019666181113122009","article-title":"Thymoquinone shows the diverse therapeutic actions by modulating multiple cell signaling pathways: single drug for multiple targets","volume":"19","author":"Khan","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153331_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112604","article-title":"Thymoquinone induces oxidative stress-mediated apoptosis through downregulation of Jak2\/STAT3 signaling pathway in human melanoma cells","volume":"157","author":"Raut","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/cimb46010010","article-title":"Thymoquinone: a promising therapeutic agent for the treatment of colorectal cancer","volume":"46","author":"Kurowska","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153331_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jddst.2018.08.019","article-title":"Enhanced efficacy and bioavailability of thymoquinone using nanoliposomal dosage form","volume":"47","author":"Mohammadabadi","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12935-023-03174-4","article-title":"Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer","volume":"23","author":"Sheikhnia","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.153331_bib34","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00210-020-01898-y","article-title":"Thymoquinone-chemotherapeutic combinations: new regimen to combat cancer and cancer stem cells","volume":"393","author":"El-Far","year":"2020","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153331_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-29-87","article-title":"Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo","volume":"29","author":"Jafri","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153331_bib36","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/jpm12111873","article-title":"Dynamical synergy of drug combinations during cancer chemotherapy","volume":"12","author":"Castorina","year":"2022","journal-title":"J. Personalized Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153331_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/ph14040369","article-title":"Thymoquinone, as a novel therapeutic candidate of cancers","volume":"14","author":"Almajali","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2026.153331_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fphar.2017.00295","article-title":"Thymoquinone as a potential adjuvant therapy for cancer treatment: evidence from preclinical studies","volume":"8","author":"Mostofa","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153331_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbrc.2011.12.063","article-title":"Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo","volume":"417","author":"Lei","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153331_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41419-019-1611-4","article-title":"Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells","volume":"10","author":"Ndreshkjana","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153331_bib41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fphar.2017.00656","article-title":"Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin","volume":"8","author":"Goyal","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153331_bib42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-07-2088","article-title":"Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis","volume":"6","author":"Sethi","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153331_bib43","doi-asserted-by":"crossref","DOI":"10.5530\/ijpi.2020.2.39","article-title":"Combination of docetaxel with thymoquinone in nanoemulsion impedes the migration of breast cancer stem cells","volume":"10","author":"Bawadud","year":"2020","journal-title":"Int. J. Pharm. Invest."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib44","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3762\/bjnano.15.96","article-title":"Synthesis, characterization and anticancer effect of doxorubicin-loaded dual stimuli-responsive smart nanopolymers","volume":"15","author":"Acet","year":"2024","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.bbrc.2026.153331_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114972","article-title":"Anticancer activity of thymoquinone against breast cancer cells: mechanisms of action and delivery approaches","volume":"165","author":"Shabani","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153331_bib46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.foodhyd.2014.07.011","article-title":"Preparation and characterization of nanoemulsion encapsulating curcumin","volume":"43","author":"Sari","year":"2015","journal-title":"Food Hydrocoll."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153331_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75017-5","article-title":"Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells","volume":"10","author":"Alkhatib","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153331_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.34172\/bi.2023.23515","article-title":"Growth and invasion inhibition of T47D ductal carcinoma cells by the association of docetaxel with a bioactive agent in neutral nanosuspension","volume":"13","author":"Bawadud","year":"2023","journal-title":"Bioimpacts: BI"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153331_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22171","article-title":"Protective effect of thymoquinone nanoemulsion in reducing the cardiotoxic effect of 5\u2010fluorouracil in rats","volume":"85","author":"Karim","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153331_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10495-009-0421-z","article-title":"Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling","volume":"15","author":"El-Najjar","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2026.153331_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112604","article-title":"Thymoquinone induces oxidative stress-mediated apoptosis through downregulation of Jak2\/STAT3 signaling pathway in human melanoma cells","volume":"157","author":"Raut","year":"2021","journal-title":"Food Chem. Toxicol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:26:17Z","timestamp":1774002377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"alternative-id":["S0006291X26000951"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153331","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoemulsion in cancer therapy: Enhancing the therapeutic efficacy of capecitabine and 5-fluorouracil in colorectal cancer with thymoquinone nanoemulsion","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153331"}}